{"id":383154,"date":"2010-03-03T06:09:36","date_gmt":"2010-03-03T11:09:36","guid":{"rendered":"http:\/\/blogs.jwatch.org\/hiv-id-observations\/?p=764"},"modified":"2010-03-03T06:09:36","modified_gmt":"2010-03-03T11:09:36","slug":"ritonavir-tablets-any-experience-out-there%c2%a0yet","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/383154","title":{"rendered":"Ritonavir Tablets:  Any Experience Out There\u00a0Yet?"},"content":{"rendered":"<p>Ritonavir <a href=\"http:\/\/blogs.jwatch.org\/hiv-id-observations\/index.php\/ritonavir-table-approved\/2010\/02\/11\/\" >tablets have been approved<\/a>, and are apparently now in pharmacies.\u00a0 The capsules will also remain available for the foreseeable future.<\/p>\n<p>However, I haven&#8217;t switched anyone over from the capsules yet, and neither has anyone else in our practice.<\/p>\n<p>Would be interested in hearing how it&#8217;s going so far &#8212; best news would be that the tablets are both more convenient <em>and<\/em> have fewer side effects, but we know from the switch to Kaletra tablets that the latter might not occur.<\/p>\n<p>(Which surprised me, I have to admit &#8212; thought the tablets would be better tolerated, but it was about the same.)<\/p>\n<p>So &#8230; if you&#8217;ve switched patients to from the capsules to the tablets, comment away!<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/HivAndIdObservations\/~4\/TMcoE-uitYM\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ritonavir tablets have been approved, and are apparently now in pharmacies.\u00a0 The capsules will also remain available for the foreseeable future. However, I haven&#8217;t switched anyone over from the capsules yet, and neither has anyone else in our practice. Would be interested in hearing how it&#8217;s going so far &#8212; best news would be that [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-383154","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/383154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=383154"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/383154\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=383154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=383154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=383154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}